Clinical Trials Directory

Trials / Unknown

UnknownNCT01021631

TRACS STUDY: Transfusion Requirements After Cardiac Surgery

Transfusion Requirements After Cardiac Surgery: a Randomized Controlled Clinical Trial (TRACS STUDY)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Instituto do Coracao · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Blood transfusion is related to worse outcomes and the triggers for red blood cells transfusion are not well defined in cardiac surgery. Retrospective studies in cardiac surgery do not show benefits of red blood cell transfusion in reduction of morbidity and mortality in cardiac surgery. There are no prospective studies comparing outcomes between restrictive or liberal strategy in cardiac surgery.This study is a double-blind randomized study comparing clinical outcomes between two strategies of transfusion in cardiac surgery - liberal or restrictive.

Detailed description

Blood transfusion is commonly performed in patients submitted to cardiac surgery. However, there are many studies reporting adverse effects of this intervention and final data on benefits are not available. There are no prospective studies in cardiac surgery regarding red blood cell transfusions requirements. There are retrospective studies in cardiac surgery suggesting worse outcomes including higher rates of mortality in patients submitted to red blood transfusion. Hematocrit levels around 30% are usually recommended not evidence based. Our purpose is to prospectively evaluate two strategies of transfusion in 500 patients submitted to elective cardiac surgery: a liberal strategy - patients receive blood transfusion when hematocrit is lower than 30% since the intraoperative period until the ICU discharge; a restrictive strategy - patients receive blood transfusion only when hematocrit is lower than 24%. Clinical outcomes, costs and quality of life will be compared.

Conditions

Interventions

TypeNameDescription
OTHERRed blood cell transfusionRed blood cell (RBC) transfusion will be given when hematocrit fall below 30% since intraoperative until the discharge of intensive care unit. Following administration of the 1 RBC unit, a repeat hematocrit is performed;if a patient's hematocrit is 30% or higher, no additional transfusion is necessary.
OTHERRed blood cell transfusionRed blood cell (RBC) transfusion will be only given when hematocrit fall below 24% since intraoperative until the discharge of intensive care unit. Following administration of the 1 RBC unit, a repeat hematocrit is performed;if a patient's hematocrit is 24% or higher, no additional transfusion is necessary.

Timeline

Start date
2009-02-01
Primary completion
2010-02-01
Completion
2010-04-01
First posted
2009-11-30
Last updated
2009-11-30

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01021631. Inclusion in this directory is not an endorsement.